Predictive factors associated with in-hospital mortality in acute myeloid leukemia patients after induction chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20240810001

Enrollment

363

Registered

2024-08-10

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid leukemia patients admitted for induction chemotherapy treatment. acute myeloid leukemia, predictor, mortality, chemotherapy

Interventions

AML after induction chemotherapy evaluate for 30-day mortality

Other

acute myeloid leukemia patients receiving chemotherapy

Eligibility

Sex/Gender

All

Age

15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adult AML patient, newly diagnosis age > 15 y plan high intensive chemotherapy

Exclusion criteria

Exclusion criteria: death before start chemotherapy change plan to palliative or low dose treatment

Design outcomes

Primary

Measure	Time frame
death 30 day death after chemotherapy at 30 day,predictive factors associated with death 30 days 30 day mortality	—

Secondary

Measure	Time frame
induction death rate 30 day death/survive at 30 days after chemotherapy,survival rate 30 day patient who survive at 30 day after chemotherapy,complete remission rate after discharge from induction chemotherapy session number of patients with complete remission evaluate after complete treatment	—

Countries

Thailand

Contacts

Public Contactthiraya akeboonyuen

phrapokklao hospital

thiraya.ake@gmail.com0934451116

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026